trending Market Intelligence /marketintelligence/en/news-insights/trending/g7lktr3lt08trbov8vmnpa2 content esgSubNav
In This List

Botanix raises A$15M via oversubscribed placement

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Botanix raises A$15M via oversubscribed placement

Australia's Botanix Pharmaceuticals Ltd. closed an oversubscribed placement of shares, raising A$15 million, before costs.

The company, which develops treatments for serious skin diseases, issued 135,777,823 shares priced 11 Australian cents each.

Botanix plans to use proceeds for its key clinical development programs, primarily BTX 1503 in acne. The company said it will use the remaining funds to help develop BTX 1204 in atopic dermatitis and BTX 1308 in psoriasis.

Bell Potter Securities Ltd. and Argonaut Securities Pty Ltd. acted as joint lead managers for the placement, with Vesparum Capital as independent capital markets adviser for Botanix.